Using Rare Disease Day to Promote Clinical Trial Participation

What is Rare Disease Day and Why It Matters for Research

Rare Disease Day, observed annually on the last day of February, is a globally recognized event aimed at raising awareness for the 300+ million people living with rare diseases worldwide. Since its inception in 2008, it has grown into a powerful movement supported by patients, caregivers, healthcare providers, industry, and researchers across more than 100 countries.

For clinical trial sponsors, Rare Disease Day presents a unique and timely opportunity to educate the public about ongoing research, increase awareness of recruiting trials, and foster partnerships with advocacy organizations. By aligning recruitment efforts with this event, sponsors can elevate visibility, build trust, and drive engagement from the rare disease community.

Integrating Clinical Trial Messaging into Rare Disease Day Activities

While Rare Disease Day is not traditionally focused on clinical trials, its mission aligns perfectly with the goals of advancing treatment and innovation. Sponsors can incorporate trial messaging into RDD events and materials without overshadowing the advocacy agenda. Tactics include:

• Dedicated Web Pages: Create Rare Disease Day-branded landing pages highlighting currently enrolling studies.
• Social Media Integration: Use hashtags like #RareDiseaseDay and #ShowYourRare in posts that link to trials on WHO ICTRP or sponsor websites.
• Patient Storytelling: Publish or share stories from previous trial participants or caregivers about their experiences in clinical research.
• Co-Hosted Events: Partner with advocacy groups to organize webinars, virtual meetups, or live Q&A sessions that include information about trial opportunities.

These approaches ensure that trial promotion is informative, respectful, and community-aligned.

Designing Rare Disease Day Campaigns with Trial Awareness in Mind

A well-crafted Rare Disease Day campaign with trial-focused content requires strategic planning. Best practices include:

• Early Start: Begin planning 3–4 months ahead to secure partnerships, speaker availability, and regulatory approvals.
• Messaging Balance: Avoid overt trial recruitment appeals. Focus instead on education, empowerment, and the role of research in treatment advancement.
• Multichannel Presence: Use a mix of infographics, patient videos, email blasts, blog posts, and social engagement to reinforce messages.
• Branded Collateral: Develop Rare Disease Day-themed visuals such as posters, ribbons, and banners co-branded with trial sponsors or CROs (subject to IRB approval).

The goal is to generate interest and awareness that naturally leads patients and families to explore research participation options.

Collaborating with Advocacy Groups and Global Partners

Rare Disease Day is organized by EURORDIS and supported by a global alliance of patient organizations. Engaging with these partners can amplify your reach and improve community reception. Steps to consider:

• Reach out to national or regional advocacy groups well in advance.
• Offer content for their newsletters, blogs, or events highlighting the importance of research and participation.
• Invite advocacy leaders to join trial awareness panels or webinars.
• Provide IRB-approved educational materials for distribution at RDD events.

These collaborations not only strengthen messaging but also build credibility within the patient community.

Ethical and Regulatory Considerations

Even during awareness campaigns, sponsors must maintain compliance with ethical standards and regulations governing clinical trial promotion. Important guidelines include:

• IRB/Ethics Committee Review: Any trial-specific messaging, especially that includes calls to action, must be reviewed and approved.
• Transparent Disclosures: Make it clear when materials are sponsored and differentiate between education and promotion.
• Patient Privacy: Avoid collecting identifiable patient data during events without explicit informed consent.
• Local Laws: Follow all applicable rules for digital and physical advertising across countries where content will be distributed.

Partnering with legal and regulatory teams early in the campaign planning process ensures smooth approvals and message integrity.

Example: Trial Awareness Campaign Tied to Rare Disease Day

In 2023, a biotech company developing a treatment for a rare metabolic disorder launched a digital awareness campaign aligned with Rare Disease Day. Components included:

• A microsite with an animated explainer on clinical trials and a list of recruiting sites
• Two live patient panels hosted in collaboration with global advocacy groups
• Social media posts featuring caregivers sharing why research matters
• Newsletter inserts sent through advocacy group mailing lists

The campaign resulted in:

• 22,000 microsite visits in one week
• Over 400 pre-screening form completions
• 12 direct enrollments into the ongoing Phase II study

This case demonstrated that timing, empathy, and collaborative outreach can drive measurable recruitment outcomes.

Measuring Campaign Effectiveness

As with any awareness initiative, tracking and analysis are vital. Metrics to consider include:

• Reach and impressions across digital channels
• Engagement metrics (shares, comments, video views)
• Clicks and conversions to trial listing pages
• Referral sources for pre-screening form submissions
• Number of inquiries or calls to action completed during events

These insights help refine future campaigns and demonstrate ROI to stakeholders and internal teams.

Conclusion: Turning Awareness into Participation

Rare Disease Day offers more than symbolic solidarity—it is a strategic opportunity to connect awareness with action. Sponsors who engage ethically, collaborate meaningfully, and communicate clearly can transform this global event into a catalyst for recruitment success.

When awareness meets access, research becomes more inclusive, empowering the rare disease community not just to observe Rare Disease Day—but to shape its future.

Creating Impactful Awareness Campaigns for Rare Disease Trial Participation

Why Awareness Campaigns Matter in Rare Disease Research

In the rare disease space, lack of awareness remains a significant barrier to patient participation in clinical trials. Many patients are unaware that trials exist for their condition, and even fewer understand the role they can play in advancing new treatments. Unlike common diseases, rare conditions often lack dedicated healthcare pathways, making targeted outreach essential for successful recruitment.

Awareness campaigns not only educate but also inspire action—empowering patients, caregivers, and even healthcare providers to seek out and participate in clinical research. A well-designed campaign builds trust, fosters dialogue, and mobilizes hard-to-reach populations to take part in trials that could lead to future therapies.

Key Components of a Rare Disease Awareness Campaign

Effective awareness campaigns for rare disease research are multi-channel, culturally sensitive, and patient-centered. Core components include:

• Clear Objectives: Define if the goal is general awareness, pre-screening, registry sign-up, or direct recruitment.
• Audience Segmentation: Tailor content for different audiences—patients, caregivers, healthcare providers, advocacy groups, or the general public.
• Compelling Messaging: Use empathetic, clear, and relatable language that resonates with the daily realities of the target community.
• Trusted Messengers: Leverage voices from within the community—advocates, clinicians, caregivers, or trial participants.
• Multi-Channel Strategy: Use a mix of social media, webinars, podcasts, posters, influencer outreach, and traditional media.

Developing Patient-Centric Messaging

The heart of any awareness campaign is its message. For rare diseases, this messaging must be inclusive, accessible, and empowering. Avoid overly scientific jargon or promotional language that may seem coercive. Instead, highlight:

• The purpose and value of clinical research
• How trials contribute to the future of treatment
• The rights and protections of participants
• What participation involves—visit schedule, procedures, and possible benefits

Consider including patient or caregiver testimonials, which humanize the message and help others see themselves in the journey. These can be delivered via video, quote graphics, or short blog-style posts.

Designing Accessible and Inclusive Campaign Materials

Campaign materials should reflect the linguistic, cultural, and educational diversity of your target population. Key considerations include:

• Multilingual Content: Translate materials into local languages and ensure accuracy via native speakers or community reviewers.
• Visual Accessibility: Use large fonts, color contrast, and visual storytelling for patients with vision or cognitive impairments.
• Plain Language: Target a 6th–8th grade reading level for general readability.
• Inclusive Imagery: Represent diverse ethnicities, ages, and abilities in all visuals.

Also consider audio versions or videos with closed captioning to ensure universal access.

Collaborating with Advocacy and Clinical Stakeholders

Partnerships with advocacy groups, key opinion leaders, and clinicians provide credibility and extend campaign reach. Stakeholders can help in:

• Co-creating messaging and materials
• Hosting webinars or Q&A sessions
• Sharing campaign content through their networks
• Providing registry access or connecting eligible patients

These collaborations should be formalized with clear roles, co-branding agreements, and compliance approvals. Transparency in sponsorship and intent is essential to maintain public trust.

Choosing the Right Channels and Formats

Channel selection depends on the demographic and geographic spread of the target community. Common campaign outlets include:

• Facebook and Instagram: For direct patient and caregiver engagement
• YouTube: For testimonial videos and explainer animations
• LinkedIn: For clinician-focused updates and sponsor branding
• Webinars: To provide interactive educational experiences
• Printed Flyers/Posters: For hospitals, clinics, and rare disease events

Explore campaigns listed on platforms like ClinicalTrials.gov to benchmark tone and structure for campaign microsites or landing pages.

Legal and Ethical Oversight of Awareness Campaigns

Awareness campaigns must comply with regional advertising laws and clinical research ethics. IRB or ethics committee approval is typically required for any material that mentions a specific study, even if it is framed as an awareness effort.

• Balanced Messaging: Avoid exaggerating trial benefits or downplaying risks.
• Disclosures: Clearly identify the sponsor and include disclaimers.
• Privacy Protection: Do not collect identifiable data through campaign forms without explicit consent.
• IRB Approval: Submit campaign content, visuals, and scripts for review, even if the content is hosted on partner sites.

Ethical compliance not only protects patients—it enhances credibility and long-term trust.

Measuring Campaign Impact and Iterating

Campaigns should include measurable KPIs (key performance indicators) to assess their reach and effectiveness. Examples include:

• Website visits or click-through rates on landing pages
• Number of inquiries or registry sign-ups
• Pre-screening form submissions
• Engagement rates on social media (likes, shares, comments)
• Campaign-driven enrollment conversions

Analyze results by channel, audience segment, and message variant to identify what works—and what doesn’t. Use A/B testing where possible to optimize messaging for future rounds.

Conclusion: Building Awareness with Purpose

Designing successful awareness campaigns for rare disease clinical trial participation requires empathy, clarity, and cross-sector collaboration. When done right, these campaigns can bridge the gap between eligible patients and potentially life-changing studies—while fostering trust, education, and community engagement along the way.

Campaigns that reflect the voices and values of the rare disease community are not just recruitment tools—they are catalysts for shared progress in the search for cures.